Urolithin A (UA) and its structural analogs reduce CRC resistance to 5-fluorouracil by modulating the forkhead box O3 (FOXO3)-forkhead box M1 (FOXM1) axis (52). The gene discussed is FOXO3; the disease is colorectal carcinoma.